Soligenix picks Dr Robert Rubin for board position
This article was originally published in Scrip
The US biopharmaceutical company Soligenix has elected Dr Robert Rubin to its board of directors. Since 1995, Dr Rubin has been a clinical professor of medicine at Georgetown University's School of Medicine. He was previously assistant surgeon general in the US public health service, and president of the national health policy and management consulting firm The Lewin Group.